Research Page 2 Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Tumor budding as a prognostic factor for treatment outcomes in patients with stage 2 colon cancer

Posted by on Aug 21, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the role of tumor budding (TB) in predicting the best treatment for stage 2 colon cancer. Researchers suggested that TB could improve the effect of chemotherapy after surgery in these patients. Some background Stage 2 colorectal cancer accounts for one-third of patients who undergo curative surgery. Prognostic...

Read More

Is levodopa-carbidopa intestinal gel an effective treatment for patients with Parkinson’s disease?

Posted by on Aug 21, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness and safety of levodopa-carbidopa intestinal gel (LCIG; Duodopa) in the treatment of patients with Parkinson's disease. Researchers suggested that LCIG alone is a safe and effective option as a treatment for these patients. Some background Parkinson disease affects brain cells. These cells...

Read More

Leflunomide – a review of its use in the treatment of juvenile idiopathic arthritis

Posted by on Aug 21, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the use of leflunomide (Arava) in juvenile idiopathic arthritis (JIA).   They found that this medication may be useful in managing JIA in patients resistant or intolerant to methotrexate.  Some background Juvenile idiopathic arthritis (JIA) is caused by inflammation in the joints. JIA is...

Read More

Evaluating different doxorubicin doses for patients with diffuse large B-cell lymphoma

Posted by on Aug 21, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated three different chemotherapy regimens with varying doses of doxorubicin (Adriamycin) for patients with diffuse large B-cell lymphoma (DLBCL). This study concluded that R-CEOP70 could be safely used instead of R-CHOP50, while R-CEOP90 may be recommended for younger patients. Some background DLBCL is one of the most...

Read More

Bexagliflozin for patients with type 2 diabetes

Posted by on Aug 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to evaluate the safety and effectiveness of bexagliflozin in patients with type 2 diabetes (T2D). The study found that this treatment was safe and significantly improved the outcomes of these patients. Some background Bexagliflozin is a new medication for treating T2D. It is part of a larger class of...

Read More

Can metformin help reduce the risk of developing neurodegenerative disease in elderly patients with T2D?

Posted by on Aug 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if metformin (Glucophage) helped reduce the risk of neurodegenerative disease in elderly patients with Type 2 diabetes (T2D). The authors found that patients taking metformin for more than two years had a lower risk of brain degeneration diseases compared to patients not taking metformin. Some...

Read More